Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 603

1.

Defining chronic inflammatory demyelinating polyradiculoneuropathy subtypes.

Hughes RAC.

J Neurol Neurosurg Psychiatry. 2019 Jun 21. pii: jnnp-2019-321250. doi: 10.1136/jnnp-2019-321250. [Epub ahead of print] No abstract available.

PMID:
31227561
2.

Childhood neurodevelopmental difficulties and risk of adolescent depression: the role of irritability.

Eyre O, Hughes RA, Thapar AK, Leibenluft E, Stringaris A, Davey Smith G, Stergiakouli E, Collishaw S, Thapar A.

J Child Psychol Psychiatry. 2019 Aug;60(8):866-874. doi: 10.1111/jcpp.13053. Epub 2019 Mar 25.

PMID:
30908655
3.

Selection Bias When Estimating Average Treatment Effects Using One-sample Instrumental Variable Analysis.

Hughes RA, Davies NM, Davey Smith G, Tilling K.

Epidemiology. 2019 May;30(3):350-357. doi: 10.1097/EDE.0000000000000972.

PMID:
30896457
4.

Accounting for missing data in statistical analyses: multiple imputation is not always the answer.

Hughes RA, Heron J, Sterne JAC, Tilling K.

Int J Epidemiol. 2019 Mar 16. pii: dyz032. doi: 10.1093/ije/dyz032. [Epub ahead of print]

PMID:
30879056
5.

More Is Not Always Better: Evaluation of 1D and 2D-LC-MS/MS Methods for Metaproteomics.

Hinzke T, Kouris A, Hughes RA, Strous M, Kleiner M.

Front Microbiol. 2019 Feb 14;10:238. doi: 10.3389/fmicb.2019.00238. eCollection 2019.

6.

Light-Mediated Growth of Noble Metal Nanostructures (Au, Ag, Cu, Pt, Pd, Ru, Ir, Rh) From Micro- and Nanoscale ZnO Tetrapodal Backbones.

Demille TB, Hughes RA, Preston AS, Adelung R, Mishra YK, Neretina S.

Front Chem. 2018 Sep 10;6:411. doi: 10.3389/fchem.2018.00411. eCollection 2018.

7.

Regional variation of Guillain-Barré syndrome.

Doets AY, Verboon C, van den Berg B, Harbo T, Cornblath DR, Willison HJ, Islam Z, Attarian S, Barroso FA, Bateman K, Benedetti L, van den Bergh P, Casasnovas C, Cavaletti G, Chavada G, Claeys KG, Dardiotis E, Davidson A, van Doorn PA, Feasby TE, Galassi G, Gorson KC, Hartung HP, Hsieh ST, Hughes RAC, Illa I, Islam B, Kusunoki S, Kuwabara S, Lehmann HC, Miller JAL, Mohammad QD, Monges S, Nobile Orazio E, Pardo J, Pereon Y, Rinaldi S, Querol L, Reddel SW, Reisin RC, Shahrizaila N, Sindrup SH, Waqar W, Jacobs BC; IGOS Consortium.

Brain. 2018 Oct 1;141(10):2866-2877. doi: 10.1093/brain/awy232.

8.

Arrays of highly complex noble metal nanostructures using nanoimprint lithography in combination with liquid-phase epitaxy.

Menumerov E, Golze SD, Hughes RA, Neretina S.

Nanoscale. 2018 Oct 4;10(38):18186-18194. doi: 10.1039/c8nr06874g.

PMID:
30246850
9.

Interventions to support shared decision making for hypertension: A systematic review of controlled studies.

Johnson RA, Huntley A, Hughes RA, Cramer H, Turner KM, Perkins B, Feder G.

Health Expect. 2018 Dec;21(6):1191-1207. doi: 10.1111/hex.12826. Epub 2018 Sep 17.

10.

Low-Cost Nanostructures from Nanoparticle-Assisted Large-Scale Lithography Significantly Enhance Thermal Energy Transport across Solid Interfaces.

Lee E, Menumerov E, Hughes RA, Neretina S, Luo T.

ACS Appl Mater Interfaces. 2018 Oct 10;10(40):34690-34698. doi: 10.1021/acsami.8b08180. Epub 2018 Sep 26.

PMID:
30209944
11.

Genome sequence, metabolic properties and cyanobacterial attachment of Porphyrobacter sp. HT-58-2 isolated from a filamentous cyanobacterium-microbial consortium.

Hughes RA, Jin X, Zhang Y, Zhang R, Tran S, Williams PG, Lindsey JS, Miller ES.

Microbiology. 2018 Oct;164(10):1229-1239. doi: 10.1099/mic.0.000706. Epub 2018 Aug 17.

PMID:
30117798
12.

Targeting TrkB with a Brain-Derived Neurotrophic Factor Mimetic Promotes Myelin Repair in the Brain.

Fletcher JL, Wood RJ, Nguyen J, Norman EML, Jun CMK, Prawdiuk AR, Biemond M, Nguyen HTH, Northfield SE, Hughes RA, Gonsalvez DG, Xiao J, Murray SS.

J Neurosci. 2018 Aug 8;38(32):7088-7099. doi: 10.1523/JNEUROSCI.0487-18.2018. Epub 2018 Jul 5.

13.

Long terms trends in CD4+ cell counts, CD8+ cell counts, and the CD4+ :  CD8+ ratio.

Hughes RA, May MT, Tilling K, Taylor N, Wittkop L, Reiss P, Gill J, Schommers P, Costagliola D, Guest JL, Lima VD, d'Arminio Monforte A, Smith C, Cavassini M, Saag M, Castilho JL, Sterne JAC.

AIDS. 2018 Jun 19;32(10):1361-1367. doi: 10.1097/QAD.0000000000001848.

14.

Long-term trends in CD4 cell counts, CD8 cell counts, and the CD4: CD8 ratio: ART Cohort Collaboration (ART-CC) Study.

Hughes RA, May MT, Tilling K, Taylor N, Wittkop L, Reiss P, Gill J, Schommers P, Costagliola D, Guest JL, Lima VD, Monforte AD, Smith C, Cavassini M, Saag M, Sterling TR, Sterne JAC.

AIDS. 2018 May 3. doi: 10.1097/QAD.0000000000001848. [Epub ahead of print]

PMID:
29734221
15.

Socioeconomic differences in childhood BMI trajectories in Belarus.

Patel R, Tilling K, Lawlor DA, Howe LD, Hughes RA, Bogdanovich N, Matush L, Nicoli E, Oken E, Kramer MS, Martin RM.

Int J Obes (Lond). 2018 Sep;42(9):1651-1660. doi: 10.1038/s41366-018-0042-0. Epub 2018 Feb 28.

16.

Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.

Hughes RA, Mehndiratta MM, Rajabally YA.

Cochrane Database Syst Rev. 2017 Nov 29;11:CD002062. doi: 10.1002/14651858.CD002062.pub4. Review.

PMID:
29185258
17.

Impact of Dietary Galacto-Oligosaccharide (GOS) on Chicken's Gut Microbiota, Mucosal Gene Expression, and Salmonella Colonization.

Hughes RA, Ali RA, Mendoza MA, Hassan HM, Koci MD.

Front Vet Sci. 2017 Nov 13;4:192. doi: 10.3389/fvets.2017.00192. eCollection 2017.

18.

Quantitation of Tolyporphins, Diverse Tetrapyrrole Secondary Metabolites with Chlorophyll-Like Absorption, from a Filamentous Cyanobacterium-Microbial Community.

Zhang Y, Zhang R, Hughes RA, Dai J, Gurr JR, Williams PG, Miller ES, Lindsey JS.

Phytochem Anal. 2018 Mar;29(2):205-216. doi: 10.1002/pca.2735. Epub 2017 Nov 6.

PMID:
29110356
19.

Guillain-Barré syndrome in the 100 years since its description by Guillain, Barré and Strohl.

Hughes RAC, Cornblath DR, Willison HJ.

Brain. 2016 Nov 1;139(11):3041-3047. doi: 10.1093/brain/aww247. No abstract available.

PMID:
29106487
20.

De novo design of antibody complementarity determining regions binding a FLAG tetra-peptide.

Entzminger KC, Hyun JM, Pantazes RJ, Patterson-Orazem AC, Qerqez AN, Frye ZP, Hughes RA, Ellington AD, Lieberman RL, Maranas CD, Maynard JA.

Sci Rep. 2017 Aug 31;7(1):10295. doi: 10.1038/s41598-017-10737-9.

21.

Genome Sequence and Composition of a Tolyporphin-Producing Cyanobacterium-Microbial Community.

Hughes RA, Zhang Y, Zhang R, Williams PG, Lindsey JS, Miller ES.

Appl Environ Microbiol. 2017 Sep 15;83(19). pii: e01068-17. doi: 10.1128/AEM.01068-17. Print 2017 Oct 1.

22.

A Brain-Derived Neurotrophic Factor-Based p75NTR Peptide Mimetic Ameliorates Experimental Autoimmune Neuritis Induced Axonal Pathology and Demyelination.

Gonsalvez DG, Tran G, Fletcher JL, Hughes RA, Hodgkinson S, Wood RJ, Yoo SW, De Silva M, Agnes WW, McLean C, Kennedy P, Kilpatrick TJ, Murray SS, Xiao J.

eNeuro. 2017 Jul 4;4(3). pii: ENEURO.0142-17.2017. doi: 10.1523/ENEURO.0142-17.2017. eCollection 2017 May-Jun.

23.

Drug therapy for chronic idiopathic axonal polyneuropathy.

Warendorf J, Vrancken AF, van Schaik IN, Hughes RA, Notermans NC.

Cochrane Database Syst Rev. 2017 Jun 20;6:CD003456. doi: 10.1002/14651858.CD003456.pub3. Review.

24.

When lithography meets self-assembly: a review of recent advances in the directed assembly of complex metal nanostructures on planar and textured surfaces.

Hughes RA, Menumerov E, Neretina S.

Nanotechnology. 2017 Jul 14;28(28):282002. doi: 10.1088/1361-6528/aa77ce. Epub 2017 Jun 7.

PMID:
28590253
25.

Estimation of the linear mixed integrated Ornstein-Uhlenbeck model.

Hughes RA, Kenward MG, Sterne JAC, Tilling K.

J Stat Comput Simul. 2017 May 24;87(8):1541-1558. doi: 10.1080/00949655.2016.1277425. Epub 2017 Jan 12.

26.

Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.

Mahdi-Rogers M, Brassington R, Gunn AA, van Doorn PA, Hughes RA.

Cochrane Database Syst Rev. 2017 May 8;5:CD003280. doi: 10.1002/14651858.CD003280.pub5. Review.

27.

International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome.

Jacobs BC, van den Berg B, Verboon C, Chavada G, Cornblath DR, Gorson KC, Harbo T, Hartung HP, Hughes RAC, Kusunoki S, van Doorn PA, Willison HJ; IGOS Consortium.

J Peripher Nerv Syst. 2017 Jun;22(2):68-76. doi: 10.1111/jns.12209.

PMID:
28406555
28.

Limited effects of source population identity and number on seagrass transplant performance.

Novak AB, Plaisted HK, Hays CG, Hughes RA.

PeerJ. 2017 Feb 28;5:e2972. doi: 10.7717/peerj.2972. eCollection 2017.

29.

Plasma exchange for Guillain-Barré syndrome.

Chevret S, Hughes RA, Annane D.

Cochrane Database Syst Rev. 2017 Feb 27;2:CD001798. doi: 10.1002/14651858.CD001798.pub3. Review.

30.

Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.

Oaklander AL, Lunn MP, Hughes RA, van Schaik IN, Frost C, Chalk CH.

Cochrane Database Syst Rev. 2017 Jan 13;1:CD010369. doi: 10.1002/14651858.CD010369.pub2. Review.

31.

Synthetic DNA Synthesis and Assembly: Putting the Synthetic in Synthetic Biology.

Hughes RA, Ellington AD.

Cold Spring Harb Perspect Biol. 2017 Jan 3;9(1). pii: a023812. doi: 10.1101/cshperspect.a023812. Review.

32.

Is Serum Albumin Associated With Guillain-Barré Syndrome Outcomes?

Hughes RA.

JAMA Neurol. 2017 Feb 1;74(2):151-153. doi: 10.1001/jamaneurol.2016.4625. No abstract available.

PMID:
28027331
33.

Catalytic Reduction of 4-Nitrophenol: A Quantitative Assessment of the Role of Dissolved Oxygen in Determining the Induction Time.

Menumerov E, Hughes RA, Neretina S.

Nano Lett. 2016 Dec 14;16(12):7791-7797. Epub 2016 Nov 30.

PMID:
27960449
34.

Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.

Pritchard J, Hughes RA, Hadden RD, Brassington R.

Cochrane Database Syst Rev. 2016 Nov 15;11:CD008630. Review.

35.

Corticosteroids for Guillain-Barré syndrome.

Hughes RA, Brassington R, Gunn AA, van Doorn PA.

Cochrane Database Syst Rev. 2016 Oct 24;10:CD001446. Review.

36.

Noble Metal Nanostructure Synthesis at the Liquid-Substrate Interface: New Structures, New Insights, and New Possibilities.

Neretina S, Hughes RA, Gilroy KD, Hajfathalian M.

Acc Chem Res. 2016 Oct 18;49(10):2243-2250. Epub 2016 Sep 13.

PMID:
27622782
37.

Regarding the past, what is the trial you have always been dreaming of in CIDP?

Hughes RA, Lunn MP.

Rev Neurol (Paris). 2016 Oct;172(10):620-626. doi: 10.1016/j.neurol.2016.07.020. Epub 2016 Sep 13. Review.

PMID:
27638135
38.

Relative efficiency of joint-model and full-conditional-specification multiple imputation when conditional models are compatible: The general location model.

Seaman SR, Hughes RA.

Stat Methods Med Res. 2018 Jun;27(6):1603-1614. doi: 10.1177/0962280216665872. Epub 2016 Sep 5.

39.

Corrigendum to "An amino acid depleted cell-free protein synthesis system for the incorporation of non-canonical amino acid analogs into proteins" [J. Biotechnol. 178 (2014) 12-22].

Singh-Blom A, Hughes RA, Ellington AD.

J Biotechnol. 2016 Aug 10;231:296. doi: 10.1016/j.jbiotec.2016.06.031. Epub 2016 Jul 16. No abstract available.

PMID:
27470576
40.

Nerve conduction velocity in CMT1A: what else can we tell?

Manganelli F, Pisciotta C, Reilly MM, Tozza S, Schenone A, Fabrizi GM, Cavallaro T, Vita G, Padua L, Gemignani F, Laurà M, Hughes RA, Solari A, Pareyson D, Santoro L; CMT-TRIAAL and CMT-TRAUK Group.

Eur J Neurol. 2016 Oct;23(10):1566-71. doi: 10.1111/ene.13079. Epub 2016 Jul 14.

41.

Citrate-Induced Nanocubes: A Re-Examination of the Role of Citrate as a Shape-Directing Capping Agent for Ag-Based Nanostructures.

Hajfathalian M, Gilroy KD, Hughes RA, Neretina S.

Small. 2016 Jul;12(25):3444-52. doi: 10.1002/smll.201600545. Epub 2016 May 13.

PMID:
27174815
42.

A Wulff in a Cage: The Confinement of Substrate-Based Structures in Plasmonic Nanoshells, Nanocages, and Nanoframes Using Galvanic Replacement.

Hajfathalian M, Gilroy KD, Golze SD, Yaghoubzade A, Menumerov E, Hughes RA, Neretina S.

ACS Nano. 2016 Jun 28;10(6):6354-62. doi: 10.1021/acsnano.6b02712. Epub 2016 May 17.

PMID:
27172588
43.

Engineering of a Novel Simplified Human Insulin-Like Peptide 5 Agonist.

Patil NA, Hughes RA, Rosengren KJ, Kocan M, Ang SY, Tailhades J, Separovic F, Summers RJ, Grosse J, Wade JD, Bathgate RA, Hossain MA.

J Med Chem. 2016 Mar 10;59(5):2118-25. doi: 10.1021/acs.jmedchem.5b01786. Epub 2016 Feb 12.

PMID:
26824523
44.

The C-terminus of the B-chain of human insulin-like peptide 5 is critical for cognate RXFP4 receptor activity.

Patil NA, Bathgate RA, Kocan M, Ang SY, Tailhades J, Separovic F, Summers R, Grosse J, Hughes RA, Wade JD, Hossain MA.

Amino Acids. 2016 Apr;48(4):987-92. doi: 10.1007/s00726-015-2144-5. Epub 2015 Dec 11.

PMID:
26661035
45.

Progress in inflammatory neuropathy -the legacy of Dr Jack Griffin.

Feldman EL, Hughes RA, Willison HJ.

Nat Rev Neurol. 2015 Nov;11(11):646-50. doi: 10.1038/nrneurol.2015.192. Epub 2015 Oct 13. Review.

PMID:
26458287
46.

Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.

Mehndiratta MM, Hughes RA, Pritchard J.

Cochrane Database Syst Rev. 2015 Aug 25;(8):CD003906. doi: 10.1002/14651858.CD003906.pub4. Review.

PMID:
26305459
47.

Responsiveness of clinical outcome measures in Charcot-Marie-Tooth disease.

Piscosquito G, Reilly MM, Schenone A, Fabrizi GM, Cavallaro T, Santoro L, Manganelli F, Vita G, Quattrone A, Padua L, Gemignani F, Visioli F, Laurà M, Calabrese D, Hughes RA, Radice D, Solari A, Pareyson D; CMT-TRIAAL Group; CMT-TRAUK Group.

Eur J Neurol. 2015 Dec;22(12):1556-63. doi: 10.1111/ene.12783. Epub 2015 Jul 31.

PMID:
26227902
48.

A Sweet Spot for Molecular Diagnostics: Coupling Isothermal Amplification and Strand Exchange Circuits to Glucometers.

Du Y, Hughes RA, Bhadra S, Jiang YS, Ellington AD, Li B.

Sci Rep. 2015 Jun 8;5:11039. doi: 10.1038/srep11039.

49.

Transformation of truncated gold octahedrons into triangular nanoprisms through the heterogeneous nucleation of silver.

Gilroy KD, Sundar A, Hajfathalian M, Yaghoubzade A, Tan T, Sil D, Borguet E, Hughes RA, Neretina S.

Nanoscale. 2015 Apr 21;7(15):6827-35. doi: 10.1039/c5nr00151j.

PMID:
25807181
50.

Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy.

Umapathi T, Hughes RA, Nobile-Orazio E, Léger JM.

Cochrane Database Syst Rev. 2015 Mar 4;(3):CD003217. doi: 10.1002/14651858.CD003217.pub5. Review.

Supplemental Content

Loading ...
Support Center